Literature DB >> 9869964

Alterations in heart rate following radiofrequency ablation in the treatment of reentrant supraventricular arrhythmias: relation to alterations in autonomic tone.

R J Verdino1, C M Tracy, A J Solomon, M Sale, J T Barbey.   

Abstract

To determine the relation between the creation of endocardial lesions and alterations in autonomic tone, we analyzed heart rate variability in patients undergoing radiofrequency catheter ablation for symptomatic supraventricular tachycardia. Elevated heart rates are frequently noted after radiofrequency catheter ablation for supraventricular arrhythmias. It has been postulated that this elevation may be secondary to alterations in cardiac autonomic tone. Since heart rate variability is a measure of autonomic nervous system activity, we used this technique to examine the heart rate elevation and to characterize postablation autonomic changes. Thirty-eight patients undergoing 44 radiofrequency catheter ablation procedures were included in the study. Total arrhythmic substrates treated included 34 accessory pathways and 13 AV nodes with dual physiology. Twenty-four hour ambulatory electrocardiographic recordings were obtained in a drug-free state prior to, ablation early postablation, and late postablation. Spectral and nonspectral analyses of heart rate variability were performed. Subgroup analyses were also done on specific cohorts. Subgroups included patients undergoing accessory pathway ablations, AV node modifications, and ablation of septal and nonseptal targets. To determine whether the amount of tissue damage was related to changes in heart rate variability, we analyzed the relation between the total energy delivered to the endocardium and the peak change in creatine kinase and heart rate variability. In this population, a significant transient increase in heart rate was noted following radiofrequency ablation. All time and frequency domain parameters of heart rate variability showed significant reversible decreases. These changes were independent of target site and arrhythmia substrate. There was no correlation noted between the changes in heart rate variability and either the total amount of energy applied to the endocardium or the change in creatine kinase. Increased heart rates and decreased heart rate variability occur following radiofrequency catheter ablation for supraventricular tachycardia. Clinically, the predominant effect is that of decreased parasympathetic tone. Since these transient changes are independent of arrhythmic substrate or ablation site in the atria, a rich parasympathetic innervation of the heart is proposed.

Entities:  

Mesh:

Year:  1997        PMID: 9869964     DOI: 10.1023/a:1009759200219

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  25 in total

1.  Mechanisms of paroxysmal supraventricular tachycardia.

Authors:  D Wu; P Denes
Journal:  Arch Intern Med       Date:  1975-03

Review 2.  Heart rate variability.

Authors:  M Malik; A J Camm
Journal:  Clin Cardiol       Date:  1990-08       Impact factor: 2.882

3.  Heart rate variability 1989. An update.

Authors:  D Van Hoogenhuyze; G J Martin; J S Weiss; J Schaad; D Fintel; D H Singer
Journal:  J Electrocardiol       Date:  1989       Impact factor: 1.438

4.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction.

Authors:  R E Kleiger; J P Miller; J T Bigger; A J Moss
Journal:  Am J Cardiol       Date:  1987-02-01       Impact factor: 2.778

5.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.

Authors:  S Akselrod; D Gordon; F A Ubel; D C Shannon; A C Berger; R J Cohen
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

6.  Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology.

Authors:  D P Zipes; J P DiMarco; P C Gillette; W M Jackman; R J Myerburg; S H Rahimtoola; J L Ritchie; M D Cheitlin; A Garson; R J Gibbons
Journal:  J Am Coll Cardiol       Date:  1995-08       Impact factor: 24.094

7.  Heart rate and heart rate variability in normal young adults.

Authors:  P Coumel; P Maison-Blanche; D Catuli
Journal:  J Cardiovasc Electrophysiol       Date:  1994-11

Review 8.  Catheter ablation for cardiac arrhythmias: clinical applications, personnel and facilities. American College of Cardiology Cardiovascular Technology Assessment Committee.

Authors: 
Journal:  J Am Coll Cardiol       Date:  1994-09       Impact factor: 24.094

9.  Selective transcatheter ablation of the fast and slow pathways using radiofrequency energy in patients with atrioventricular nodal reentrant tachycardia.

Authors:  M R Jazayeri; S L Hempe; J S Sra; A A Dhala; Z Blanck; S S Deshpande; B Avitall; D P Krum; C J Gilbert; M Akhtar
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

Review 10.  Supraventricular tachycardia: mechanisms and management.

Authors:  M E Josephson; J A Kastor
Journal:  Ann Intern Med       Date:  1977-09       Impact factor: 25.391

View more
  2 in total

1.  Heart rate variability: does it change after RF ablation of reentrant supraventricular tachycardia?

Authors:  Z Emkanjoo; M Alasti; A Arya; M Haghjoo; M R Dehghani; A F Fazelifar; R Heydari; M A Sadr-Ameli
Journal:  J Interv Card Electrophysiol       Date:  2006-01-18       Impact factor: 1.900

2.  Evaluation of the effect of radiofrequency catheter ablation on autonomic function in patients with atrioventricular nodal reentrant tachycardia by head-up tilt table test.

Authors:  Mohammad Vahid Jorat; Sayyed Ali Eftekharzadeh; Masoud Mirzaei; Mohammadbagher Owlia; Nasser Hosein Sartipzadeh; Maryam-Alsadat Salami; Mohammadreza Vafaeenasab; Ali Akbar Rahimianfar; Marzieh Shamibaf; Minoo Jafarieh; Zeynolabedin Seyfpourshouraki; Mohammadtaghi Sarebanhassanabadi
Journal:  Adv Biomed Res       Date:  2015-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.